Literature DB >> 19035305

Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorphism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation.

Alessandra Trojani1, Carla Barbara Ripamonti, Silvana Penco, Alessandro Beghini, Gianpaolo Nadali, Eros Di Bona, Assunta Viola, Carlo Castagnola, Patrizia Colapietro, Giovanni Grillo, Laura Pezzetti, Erica Ravelli, Maria Cristina Patrosso, Alessandro Marocchi, Antonio Cuneo, Felicetto Ferrara, Mario Lazzarino, Giovanni Pizzolo, Roberto Cairoli, Enrica Morra.   

Abstract

BACKGROUND: Mutations involving KIT and FLT3 genes, encoding tyrosine kinase (TK) membrane receptors, are detected in core-binding factor leukaemia (CBFL) patients. PDFGRA and PDGFRB encode class III TK receptors and are involved both in physiological processes and in the pathogenesis of haematological and solid tumours. The aim of this study was to investigate if PDGFR mutations are involved in CBFL. PATIENTS AND METHODS: In order to detect PDGFR mutations in CBFL, 35 patients without KIT or FLT3 mutations patients were screened by rapid and sensitive single-strand conformation polymorphism (SSCP) analysis. Sequence analysis was performed in polymerase chain reaction (PCR) products showing altered mobility in SSCP analysis in order to determine the nucleotide changes.
RESULTS: Three types of single-nucleotide polymorphism (SNP) were detected in the PDGFRA gene (exon 12, exon 13 and exon 18) while no mutation of PDGFRB was detected in the tested CBFLs.
CONCLUSION: These data showed that no pathogenic mutations in PDGFRA and PDGFRB were detected in the context of CBFL without KIT and FLT3 mutations. Thus, PDGFR genes do not seem to be involved in CBFL and future studies are needed to establish the genetic causes of the disease in these particular patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035305

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome.

Authors:  Purificacion Estevez-Garcia; Angel Castaño; Ana C Martin; Fernando Lopez-Rios; Joaquin Iglesias; Sandra Muñoz-Galván; Iker Lopez-Calderero; Sonia Molina-Pinelo; Maria D Pastor; Amancio Carnero; Luis Paz-Ares; Rocio Garcia-Carbonero
Journal:  BMC Cancer       Date:  2012-11-12       Impact factor: 4.430

Review 2.  Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory Analysis.

Authors:  Rimma Berenstein
Journal:  Biomark Insights       Date:  2015-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.